Cargando…
Major advances in the treatment of multiple myeloma in American Society of Hematology annual meeting 2020
Treatment of multiple myeloma (MM) has advanced dramatically in the past two decades. However, under the conditions of the COVID-19 pandemic, treatment strategies have been modified accordingly. Numerous novel agents, updated trials, and major advances in myeloma have been reported in the American S...
Autores principales: | Du, Jianhua, Zhuang, Junling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579022/ https://www.ncbi.nlm.nih.gov/pubmed/34786541 http://dx.doi.org/10.1016/j.cdtm.2021.08.003 |
Ejemplares similares
-
Interesting news from the annual meeting of the American Society of Hematology 2020
por: Gunsilius, Eberhard
Publicado: (2021) -
Report from the virtual American Society of Hematology (ASH) Annual Meeting, December 5th–8th, 2020
Publicado: (2021) -
Multiple Myeloma: Clinical Updates from the American Society of Clinical Oncology Annual Scientific Symposium 2020
por: Devarakonda, Srinivas, et al.
Publicado: (2020) -
Meeting report from the 2020 Annual (virtual) Meeting of the American Society of Clinical Oncology
por: Salani, Ritu, et al.
Publicado: (2020) -
American Nuclear Society Annual Meeting
Publicado: (1991)